Arteriovenous Malformations
Introduction of Onyx, a nonadhesive liquid embolic agent, a decade ago increased the number of dural arteriovenous fistulas (dAVFs) treated endovascularly and is associated with improved outcomes, according to a single-center retrospective analysis published online September 2, 2016, ahead of print in the Journal of Neurosurgery.
A new study on the effects of radiation in children treated for intracranial vascular malformations has shown that collimation may be able to reduce the likelihood that these patients will go on to develop a tumor. Certain technical and operator-related factors can also help decrease patient exposure at no cost to image quality, researchers report in their paper published online September 5, 2016, in the Journal of NeuroInterventional Surgery.…
Outcomes of endovascular treatment for cerebral arteriovenous malformations (AVMs) have held steady before and after the introduction of Onyx into clinical practice, according to a paper published in the Journal of Neurosurgery.…
Page 3 of 3